Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists say

The decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scientists added, pitching for a preventive like the one being developed by US firm Novavax that can be stored at lower temperatures rather than those developed from mRNA or viral vectors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32U9Med
via IFTTT